Similar articles for PMID: 28341370

Year	Number of Results
1983	1
1993	1
1995	1
1997	1
1998	2
1999	1
2002	2
2005	3
2006	2
2007	4
2008	1
2011	2
2013	4
2014	5
2015	7
2016	16
2017	10
2018	12
2019	7
2020	11
2021	11
2022	5
2023	2
2024	0

1

Management of smoldering myeloma: Recommendations of the Spanish Myeloma Group.

Mateos MV, Bladé J, Lahuerta JJ, San-Miguel J. Mateos MV, et al. Med Clin (Barc). 2017 Jun 7;148(11):517-523. doi: 10.1016/j.medcli.2017.02.012. Epub 2017 Mar 22. Med Clin (Barc). 2017. PMID: 28341370 English, Spanish. No abstract available.

2

Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer.

Muchtar E, Kumar SK, Magen H, Gertz MA. Muchtar E, et al. Leuk Lymphoma. 2018 Feb;59(2):288-299. doi: 10.1080/10428194.2017.1334124. Epub 2017 Jun 8. Leuk Lymphoma. 2018. PMID: 28592156 Review.

3

The difficult business of assessing new therapies for smouldering multiple myeloma.

Zonder JA. Zonder JA. Br J Haematol. 2018 Aug;182(4):463-464. doi: 10.1111/bjh.15385. Epub 2018 May 16. Br J Haematol. 2018. PMID: 29767407 Free article. No abstract available.

4

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management.

Maciocia N, Wechalekar A, Yong K. Maciocia N, et al. Hematol Oncol. 2017 Dec;35(4):432-439. doi: 10.1002/hon.2345. Epub 2016 Nov 2. Hematol Oncol. 2017. PMID: 27804161

5

Smoldering multiple myeloma: evolving diagnostic criteria and treatment strategies.

Visram A, Cook J, Warsame R. Visram A, et al. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):673-681. doi: 10.1182/hematology.2021000304. Hematology Am Soc Hematol Educ Program. 2021. PMID: 34889380 Free PMC article.

6

How I approach smoldering multiple myeloma.

Vaxman I, Gertz MA. Vaxman I, et al. Blood. 2022 Aug 25;140(8):828-838. doi: 10.1182/blood.2021011670. Blood. 2022. PMID: 35576526 Free PMC article. Review.

7

Clinical Controversies in the Management of Smoldering Multiple Myeloma.

Lomas OC, Ghobrial IM. Lomas OC, et al. Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-6. doi: 10.1200/EDBK_278911. Am Soc Clin Oncol Educ Book. 2020. PMID: 32223666 Free article.

8

Timing treatment for smoldering myeloma: is earlier better?

Hernández JÁ, Martínez-López J, Lahuerta JJ. Hernández JÁ, et al. Expert Rev Hematol. 2019 May;12(5):345-354. doi: 10.1080/17474086.2019.1599281. Epub 2019 Apr 4. Expert Rev Hematol. 2019. PMID: 30907176

9

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice.

Cocito F, Mangiacavalli S, Ferretti VV, Cartia CS, Ganzetti M, Benveuti P, Pompa A, Catalano M, Fugazza E, Landini B, Arcaini L, Corso A. Cocito F, et al. Leuk Lymphoma. 2019 Dec;60(12):2968-2974. doi: 10.1080/10428194.2019.1620948. Epub 2019 Jun 6. Leuk Lymphoma. 2019. PMID: 31169049

10

Smoldering multiple myeloma: biology, clinical manifestations and management.

Nsiala L, Bobin A, Levy A, Gruchet C, Sabirou F, Gardeney H, Cailly L, Manier S, Moya N, Tomowiak C, Guidez S, Leleu X, Decaux O. Nsiala L, et al. Leuk Lymphoma. 2022 Mar;63(3):518-529. doi: 10.1080/10428194.2021.1992615. Epub 2021 Oct 21. Leuk Lymphoma. 2022. PMID: 34672244

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year